Perspective
Our work in Perspective
-
California’s Marijuana Market is Crumbling
The nation’s largest state should rescue its disintegrating cannabis market by raising the cost to illicit producers and sellers, not by violating federal law.
Categorized in -
A Simple Way to Reduce Overdose Deaths: Tell Doctors When Patients Die
If they think that the crisis is happening elsewhere, clinicians may underestimate the risk.
Categorized in -
American Life in Realtime: a Benchmark Registry of Health Data for Equitable Precision Health
Applying artificial intelligence and machine learning to person-generated health data allows unprecedented assessment of associations between everyday life and health outcomes.
Categorized in -
The FDA is the Right Agency to Regulate CBD Products, but It Needs Help
Undefined and unregulated, CBD will continue to pose unnecessary risks and never reach its potential as a legitimate health supplement.
Categorized in -
Small Cannabis Producers Have Bigger Problems than State Taxes and Regulation
Removing regulations and taxes on cannabis sales would take away resources that are needed to address legitimate public health concerns and won’t solve the supply-side problem.
Categorized in -
A New Approach to Cancer Bundled Payments in Medicare—The Enhancing Oncology Model
Schaeffer Nonresident Senior Fellow Bob Kocher discusses the elements of CMMI’s new Enhancing Oncology Model, explores its likelihood of success, and discusses its relative shortcomings in a new JAMA Health Forum Viewpoint.
Categorized in -
Shame Won’t Solve America’s Obesity Crisis: How Congress Can Help
If saving lives is the objective, then logic, clinical evidence and compassion dictate that Medicare should pay for preventing and treating obesity, starting now.
Categorized in -
The Inflation Reduction Act Is Already Killing Potential Cures
The law’s price controls do away with incentives for research and development of life-saving drugs.
Categorized in -
Multi-Year Medicare Physician Fee Freeze Threatens Access: Pair Relief With Reforms
With fees frozen, high inflation threatens access to care and has other consequences.
Categorized in -
CMS’s Alzheimer’s Coverage Policy Will Inhibit Access and Discourage Innovation
Individuals in underserved communities have to travel long distances, well beyond the 30-minute standard, to access clinical trial sites for Aduhelm.
Categorized in